[HTML][HTML] Assays for determining pertussis toxin activity in acellular pertussis vaccines
K Markey, C Asokanathan, I Feavers - Toxins, 2019 - mdpi.com
Whooping cough is caused by the bacterium Bordetella pertussis. There are currently two
types of vaccines that can prevent the disease; whole cell vaccines (WCV) and acellular …
types of vaccines that can prevent the disease; whole cell vaccines (WCV) and acellular …
[HTML][HTML] Pertussis toxin: a key component in pertussis vaccines?
KA Gregg, TJ Merkel - Toxins, 2019 - mdpi.com
B. pertussis is a human-specific pathogen and the causative agent of whooping cough. The
ongoing resurgence in pertussis incidence in high income countries is likely due to faster …
ongoing resurgence in pertussis incidence in high income countries is likely due to faster …
Toward a mechanism-based in vitro safety test for pertussis toxin
SFC Vaessen, MWP Bruysters… - Human vaccines & …, 2014 - Taylor & Francis
Pertussis vaccines are routinely administered to infants to protect them from whooping
cough. Still, an adequate safety test for pertussis toxin (PT), one of the main antigens in …
cough. Still, an adequate safety test for pertussis toxin (PT), one of the main antigens in …
[PDF][PDF] Alternative safety testing strategies for acellular pertussis vaccines
R Isbrucker - ALTEX Proceedings, 2012 - proceedings.altex.org
The mouse histamine sensitization test (HIST) is the currently accepted regulatory method
used to monitor residual pertussis toxin (PTx) activity in acellular pertussis vaccines. This …
used to monitor residual pertussis toxin (PTx) activity in acellular pertussis vaccines. This …
Approaches to the control of acellular pertussis vaccines
MJ Corbel, DKL Xing, B Bolgiano, DJ Hockley - Biologicals, 1999 - Elsevier
The quality control of acellular pertussis vaccines presents particular problems related to the
differences in composition and method of detoxification used in the various type of …
differences in composition and method of detoxification used in the various type of …
Target alternative vaccine safety testing strategies for Pertussis toxin
JL Arciniega, L Corvette, H Hsu, F Lynn, T Romani… - Procedia in …, 2011 - Elsevier
All acellular pertussis (aP) vaccines in use contain chemically inactivated pertussis toxin
(PT). The finding that mice, naturally resistant to the effects of histamine, become sensitive …
(PT). The finding that mice, naturally resistant to the effects of histamine, become sensitive …
[HTML][HTML] Towards replacement of the acellular pertussis vaccine safety test: Comparison of in vitro cytotoxic activity and in vivo activity in mice
LD Wagner, LJ Corvette, MM Ngundi, DL Burns - Vaccine, 2017 - Elsevier
Because of the exquisite sensitivity of the murine histamine sensitization test (HIST) in
detecting minute amounts of active pertussis toxin (PTx), this animal-based test has been …
detecting minute amounts of active pertussis toxin (PTx), this animal-based test has been …
A need for careful evaluation of endotoxin contents in acellular pertussis-based combination vaccines
M Kataoka, M Ochiai, A Yamamoto, Y Horiuchi - Biologicals, 2012 - Elsevier
Two batches each of diphtheria-tetanus-acellular pertussis vaccine (DTaP) and that
combined with inactivated polio vaccine purchased from foreign markets were tested by …
combined with inactivated polio vaccine purchased from foreign markets were tested by …
Modified binding assay for improved sensitivity and specificity in the detection of residual pertussis toxin in vaccine preparations
RA Isbrucker, A Bliu, F Prior - Vaccine, 2010 - Elsevier
A binding assay was recently published that differentiates between pertussis toxin (PTx) and
the pertussis toxoid (PTd) used in acellular pertussis vaccines based on the selective …
the pertussis toxoid (PTd) used in acellular pertussis vaccines based on the selective …
Recombinant acellular pertussis vaccine—from the laboratory to the clinic: improving the quality of the immune response
Vaccination is the most effective way to prevent infectious diseases. Recombinant DNA
technologies have provided powerful new tools to develop vaccines that were previously …
technologies have provided powerful new tools to develop vaccines that were previously …